Tufts Center for the Study of Drug Development
Formation | 1976 |
---|---|
Founder | Louis Lasagna |
Type | |
Purpose | Researching drug development |
Location |
|
Director | Kenneth Getz |
Website | csdd |
The Tufts Center for the Study of Drug Development is an independent, academic, non-profit research center at Tufts University in Boston, dedicated to researching drug development. It was established in 1976 by American physician Louis Lasagna.[1] The Center develops and publishes information to help researchers, regulators, and policy makers in areas related to the pharmaceutical and biotechnology industries. In any given year, approximately 55% of Tufts CSDD’s operating expenses are supported by grants from the private sector and 45% from the public sector.[2][3]
Research[]
The Center studies trends in the pharmaceutical industry, maintaining databases pertaining to investigational new drugs, approved drugs, biopharmaceuticals, fast-tracked drugs, and orphan drugs.[4] The Center provides this information with the aim to improve the efficiency of drug development, foster innovation, and increase patient access to medicines.[5]
Drug development costs[]
The Center has published numerous studies estimating the cost of developing new pharmaceutical drugs. In 2001, researchers from the Center estimated that the cost of doing so was $802 million,[6] and in 2014, they released a study estimating that this amount had risen to nearly $2.6 billion.[3] The 2014 study was criticized by Medecins Sans Frontieres, which said it was unreliable because the industry's research and development spending is not made public.[7] Aaron Carroll of the New York Times also criticized the study, saying it "contains a lot of assumptions that tend to favor the pharmaceutical industry."[8] The Center's 2016 estimate, published in the Journal of Health Economics, found the cost to have averaged $2.87 billion (in 2013 dollars).[9]
References[]
- ^ "History". Tufts Center for the Study of Drug Development.
- ^ "Financial Disclosure". Tufts Center for the Study of Drug Development.
- ^ Jump up to: a b Silverman, Ed (20 November 2014). "What Does It Cost to Develop a New Drug? Latest Study Says $2.6 Billion". Wall Street Journal. Retrieved 21 November 2014.
- ^ "Databases". Tufts Center for the Study of Drug Development.
- ^ "Research Platforms and Current Research Agenda". Tufts Center for the Study of Drug Development.
- ^ Pear, Robert (1 December 2001). "Research Cost For New Drugs Said to Soar". New York Times. Retrieved 21 November 2014.
- ^ Pierson, Ransdell (18 November 2014). "CORRECTED-Tufts says average new drug costs $2.6 bln to develop, critics wary". Reuters. Retrieved 21 November 2014.
- ^ Carroll, Aaron (19 November 2014). "$2.6 Billion to Develop a Drug? New Estimate Makes Questionable Assumptions". New York Times. Retrieved 25 November 2014.
- ^ Joseph A. DiMasi, Henry G. Grabowski, Ronald W. Hansen (2016). "Innovation in the pharmaceutical industry: New estimates of R&D costs" (PDF). Journal of Health Economics. 47: 20–33. doi:10.1016/j.jhealeco.2016.01.012. hdl:10161/12742. PMID 26928437.CS1 maint: uses authors parameter (link)
- Tufts University
- 1976 establishments in Massachusetts
- Non-profit organizations based in Boston
- Organizations established in 1976
- Drug discovery